Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5b

Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5b

Aurobindo Pharma. Photo: Bloomberg

Reuters

20 August, 2025

Advent InternationalAurobindo Pharma

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.